Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
Fuente:
arXiv
Saved in:
| Main Authors: | Yamada, Kana, Sunami, Hisato, Takeda, Kentaro, Hanada, Keisuke, Kojima, Masahiro |
|---|---|
| Format: | Preprint |
| Published: |
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Random Effect Restricted Mean Survival Time Model
by: Hanada, Keisuke, et al.
Published: (2024)
by: Hanada, Keisuke, et al.
Published: (2024)
A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
by: Kojima, Masahiro, et al.
Published: (2025)
by: Kojima, Masahiro, et al.
Published: (2025)
Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)
by: Sunami, Hisato, et al.
Published: (2024)
Bayesian Parametric Methods for Deriving Distribution of Restricted Mean Survival Time
by: Hanada, Keisuke, et al.
Published: (2024)
by: Hanada, Keisuke, et al.
Published: (2024)
Integrate Meta-analysis into Specific Study (InMASS) for Estimating Conditional Average Treatment Effect
by: Hanada, Keisuke, et al.
Published: (2025)
by: Hanada, Keisuke, et al.
Published: (2025)
STAMP: A shot-type-aware areal multilevel Poisson model for league-wide comparison of basketball shot charts
by: Yamada, Kazuhiro, et al.
Published: (2026)
by: Yamada, Kazuhiro, et al.
Published: (2026)
Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
by: Silva, Rebecca B., et al.
Published: (2025)
by: Silva, Rebecca B., et al.
Published: (2025)
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)
by: Chen, Yuxuan, et al.
Published: (2026)
Eliciting prior information from clinical trials via calibrated Bayes factor
by: Demartino, Roberto Macrì, et al.
Published: (2024)
by: Demartino, Roberto Macrì, et al.
Published: (2024)
A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)
by: Li, Yuhan, et al.
Published: (2024)
Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)
by: Lee, Kyong Ju, et al.
Published: (2025)
Prior Smoothing for Multivariate Disease Mapping Models
by: Retegui, Garazi, et al.
Published: (2026)
by: Retegui, Garazi, et al.
Published: (2026)
Prior Elicitation for Generalised Linear Models and Extensions
by: Hosack, Geoffrey R.
Published: (2023)
by: Hosack, Geoffrey R.
Published: (2023)
Sample size re-estimation in blinded hybrid-control design using inverse probability weighting
by: Kojima, Masahiro, et al.
Published: (2025)
by: Kojima, Masahiro, et al.
Published: (2025)
GenAI Powered Dynamic Causal Inference with Unstructured Data
by: Nakamura, Kentaro, et al.
Published: (2026)
by: Nakamura, Kentaro, et al.
Published: (2026)
Optimal Priors for the Discounting Parameter of the Normalized Power Prior
by: Shen, Yueqi, et al.
Published: (2023)
by: Shen, Yueqi, et al.
Published: (2023)
Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025)
by: Zhang, Jiangshan, et al.
Published: (2025)
An information metric for comparing and assessing informative interim decisions in sequential clinical trials
by: Caruso, G., et al.
Published: (2025)
by: Caruso, G., et al.
Published: (2025)
Robust Emax Model Fitting: Addressing Nonignorable Missing Binary Outcome in Dose-Response Analysis
by: Zhang, Jiangshan, et al.
Published: (2024)
by: Zhang, Jiangshan, et al.
Published: (2024)
A Bayesian Hybrid Design with Borrowing from Historical Study
by: Lu, Zhaohua, et al.
Published: (2024)
by: Lu, Zhaohua, et al.
Published: (2024)
Sensitivity Analysis of Priors in the Bayesian Dirichlet Auto-Regressive Moving Average Model
by: Katz, Harrison, et al.
Published: (2025)
by: Katz, Harrison, et al.
Published: (2025)
Model-assisted analysis of covariance estimators for stepped wedge cluster randomized experiments
by: Chen, Xinyuan, et al.
Published: (2023)
by: Chen, Xinyuan, et al.
Published: (2023)
Feasible Dose-Response Curves for Continuous Treatments Under Positivity Violations
by: Bao, Han, et al.
Published: (2025)
by: Bao, Han, et al.
Published: (2025)
Causally Sound Priors for Binary Experiments
by: Irons, Nicholas J., et al.
Published: (2023)
by: Irons, Nicholas J., et al.
Published: (2023)
Generalizing conditional average treatment effects from nested randomized trials to all trial-eligible individuals
by: Wen, Lan, et al.
Published: (2026)
by: Wen, Lan, et al.
Published: (2026)
Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
by: Gao, Yujing, et al.
Published: (2025)
by: Gao, Yujing, et al.
Published: (2025)
HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
by: Shi, Junming, et al.
Published: (2024)
by: Shi, Junming, et al.
Published: (2024)
DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
by: Yang, Cheng-Han, et al.
Published: (2024)
by: Yang, Cheng-Han, et al.
Published: (2024)
Prior selection for the precision parameter of Dirichlet Process Mixtures
by: Vicentini, Carlo, et al.
Published: (2025)
by: Vicentini, Carlo, et al.
Published: (2025)
Bayes Factor of Zero Inflated Models under Jeffereys Prior
by: Pramanik, Paramahansa, et al.
Published: (2024)
by: Pramanik, Paramahansa, et al.
Published: (2024)
Model-assisted estimation for MRV: How to boost the economics of SOC sequestration projects without compromising on scientific integrity
by: Awad, Ahmad, et al.
Published: (2025)
by: Awad, Ahmad, et al.
Published: (2025)
Continuous monitoring of delayed outcomes in basket trials
by: Diniz, Marcio A., et al.
Published: (2026)
by: Diniz, Marcio A., et al.
Published: (2026)
Prior distributions for Gaussian processes in computer model emulation and calibration
by: Gu, Mengyang, et al.
Published: (2025)
by: Gu, Mengyang, et al.
Published: (2025)
Optimal scheduling of interim analyses in group sequential trials
by: He, Zhangyi, et al.
Published: (2025)
by: He, Zhangyi, et al.
Published: (2025)
Data-driven controlled subgroup selection in clinical trials
by: Müller, Manuel M., et al.
Published: (2025)
by: Müller, Manuel M., et al.
Published: (2025)
Weighting methods for truncation by death in cluster-randomized trials
by: Isenberg, Dane, et al.
Published: (2024)
by: Isenberg, Dane, et al.
Published: (2024)
The R.O.A.D. to clinical trial emulation
by: Bertsimas, Dimitris, et al.
Published: (2024)
by: Bertsimas, Dimitris, et al.
Published: (2024)
Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)
by: Hall, Andrew, et al.
Published: (2025)
A simple strategy for valid inference in target trial emulations
by: Stensrud, Mats Julius
Published: (2026)
by: Stensrud, Mats Julius
Published: (2026)
Sensitivity analysis for contamination in egocentric-network randomized trials with interference
by: Weinstein, Bar, et al.
Published: (2026)
by: Weinstein, Bar, et al.
Published: (2026)
Similar Items
-
Random Effect Restricted Mean Survival Time Model
by: Hanada, Keisuke, et al.
Published: (2024) -
A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
by: Kojima, Masahiro, et al.
Published: (2025) -
Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024) -
Bayesian Parametric Methods for Deriving Distribution of Restricted Mean Survival Time
by: Hanada, Keisuke, et al.
Published: (2024) -
Integrate Meta-analysis into Specific Study (InMASS) for Estimating Conditional Average Treatment Effect
by: Hanada, Keisuke, et al.
Published: (2025)